Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone liposome in diffuse large B-cell and peripheral T/NK-cell lymphoma
CTR20160369Phase 2Completed
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Jun 2016
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone in diffuse large B-cell lymphoma (DLBCL), T/NK-cell lymphoma (ENKTCL), sponsored by CSPC Pharmaceutical Group. Started Jun 2016; status: completed.
02
Drugs
mitoxantrone
03
Conditions
diffuse large B-cell lymphoma (DLBCL)T/NK-cell lymphoma (ENKTCL)
Beyond the preview
Go deeper on CTR20160369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160369.